Show simple item record

dc.contributor.authorPihlak, Rille
dc.contributor.authorAlmond, R
dc.contributor.authorSrivastava, P
dc.contributor.authorRaja, H
dc.contributor.authorBroadbent, Rachel
dc.contributor.authorHopewell, Louise
dc.contributor.authorHigham, Claire E
dc.contributor.authorLamarca, Angela
dc.contributor.authorHubner, Richard A
dc.contributor.authorValle, Juan W
dc.contributor.authorMcNamara, Mairead G
dc.date.accessioned2019-04-29T09:48:53Z
dc.date.available2019-04-29T09:48:53Z
dc.date.issued2018en
dc.identifier.citationPihlak R, Almond R, Srivastava P, Raja H, Broadbent R, Hopewell L, et al. 751P Effects of random glucose (Glc) levels on outcomes of patients (pts) with pancreatic ductal adenocarcinoma (PDAC). Annals of Oncology. 2018;29(suppl_8).en
dc.identifier.pmidNo PMIDen
dc.identifier.doi10.1093/annonc/mdy282.134en
dc.identifier.urihttp://hdl.handle.net/10541/621728
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdy282.134en
dc.titleEffects of random glucose (Glc) levels on outcomes of patients (pts) with pancreatic ductal adenocarcinoma (PDAC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMedical Oncology/Division of Cancer Sciences, The Christie NHS Foundation Trust/University of Manchester, Manchester, UKen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record